ACM Research, Inc.
ACMRTechnologyNASDAQSemiconductor Equipment & Materials
Scan Results
Daily timeframeHeadquartered within the technology sector, ACM Research, Inc. focuses on Semiconductor Equipment & Materials services and products. ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells capital equipment in Mainland China and internationally. The $5.36B market capitalization puts ACMR squarely in mid-cap range for its industry. It also develops, manufactures, and sells a range of packaging tools to wafer assembly and packaging customers.
Market Cap
$5.36B
Beta
1.95
P/E (TTM)
36.28
P/E (Fwd)
26.59
EPS (TTM)
$2.12
EPS (Fwd)
$2.89
ROE
11.6%
ROA
3.2%
Cash
$1.44B
Total Debt
$349.3M
Free CF
-$186.6M
52W Change
165.3%
Annual Financials
Cash vs Debt
Where ACMR stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, ACMR finished 0.20% below its 150-day moving average ($70.04) and 11.22% above its 200-day moving average ($62.85). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ACMR overbought or oversold?
At the September 3, 2026 close, ACMR's RSI(14) was 32.9, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $1.44B in cash and $349.3M in debt, ACMR maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company is burning cash, with free cash flow at -$186.6M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of 11.6% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.2% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $259.8M (2021) to $901.3M (2025), reflecting a 247% increase over the period.
ACM Research, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. With cash comfortably exceeding debt, ACMR has financial flexibility that may help navigate uncertain periods. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence ACM Research, Inc.'s trajectory.